These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10525817)

  • 21. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases--a prospective randomized study in patients with chronic liver damage.
    Kanematsu M; Semelka RC; Matsuo M; Kondo H; Enya M; Goshima S; Moriyama N; Hoshi H
    Radiology; 2002 Nov; 225(2):407-15. PubMed ID: 12409573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced timing robust acquisition order with a preparation of the longitudinal signal component (CENTRA plus) for 3D contrast-enhanced abdominal imaging.
    Beck GM; De Becker J; Jones AC; von Falkenhausen M; Willinek WA; Gieseke J
    J Magn Reson Imaging; 2008 Jun; 27(6):1461-7. PubMed ID: 18504734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels.
    Fink C; Puderbach M; Ley S; Plathow C; Bock M; Zuna I; Kauczor HU
    Invest Radiol; 2004 Mar; 39(3):143-8. PubMed ID: 15076006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging of the pancreas at 3.0 tesla: qualitative and quantitative comparison with 1.5 tesla.
    Edelman RR; Salanitri G; Brand R; Dunkle E; Ragin A; Li W; Mehta U; Berlin J; Newmark G; Gore R; Patel B; Carillo A; Vu A
    Invest Radiol; 2006 Feb; 41(2):175-80. PubMed ID: 16428989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overhauser-enhanced MR imaging (OMRI).
    Golman K; Leunbach I; Ardenkjaer-Larsen JH; Ehnholm GJ; Wistrand LG; Petersson JS; Järvi A; Vahasalo S
    Acta Radiol; 1998 Jan; 39(1):10-7. PubMed ID: 9498861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate.
    Schmid-Tannwald C; Herrmann K; Oto A; Panteleon A; Reiser M; Zech C
    Acta Radiol; 2012 Nov; 53(9):961-5. PubMed ID: 23024179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
    Runge VM
    J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium.
    Asbach P; Warmuth C; Stemmer A; Rief M; Huppertz A; Hamm B; Taupitz M; Klessen C
    Invest Radiol; 2008 Nov; 43(11):809-15. PubMed ID: 18923261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T.
    Wang CL; Chea YW; Boll DT; Samei E; Neville AM; Dale BM; Merkle EM
    Eur J Radiol; 2011 Nov; 80(2):e1-7. PubMed ID: 20646887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences.
    Marcos HB; Semelka RC
    J Magn Reson Imaging; 1999 Dec; 10(6):950-60. PubMed ID: 10581508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cisterna chyli: enhancement on delayed phase MR images after intravenous administration of gadolinium chelate.
    Verma SK; Mitchell DG; Bergin D; Mehta R; Chopra S; Choi D
    Radiology; 2007 Sep; 244(3):791-6. PubMed ID: 17652192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dynamic MR imaging of the upper abdomen: timing optimization and pulse sequence selection].
    Yoshimitsu K; Honda H
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):408-13. PubMed ID: 11524816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate.
    Hadizadeh DR; Von Falkenhausen M; Kukuk GM; Schöneseiffen K; Gieseke J; Schild HH; Willinek WA
    AJR Am J Roentgenol; 2010 Mar; 194(3):821-9. PubMed ID: 20173166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ; Prince MR; Chenevert TL
    Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison.
    Schneider G; Maas R; Schultze Kool L; Rummeny E; Gehl HB; Lodemann KP; Kirchin MA
    Invest Radiol; 2003 Feb; 38(2):85-94. PubMed ID: 12544071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.